
Intuitive Surgical (ISRG) Stock Forecast & Price Target
Intuitive Surgical (ISRG) Analyst Ratings
Bulls say
Intuitive Surgical is a global technology leader in robotic-assisted, minimally invasive surgery, and with over 10,000 da Vinci systems placed worldwide, the company has established a strong market presence and continues to expand its footprint in emerging markets. With a growing number of installations in the US and a positive outlook for procedure growth, the company's revenue and earnings are expected to see steady growth in the coming years. Risks to consider include competition and potential challenges in the procedural and capital purchasing environment.
Bears say
Intuitive Surgical is facing various challenges in the near term, including increased competition in certain regions, pricing pressure, and policy-driven headwinds in China and Japan. While the company's ecosystem and key metrics such as procedure growth and I&A per procedure remain strong, these challenges could potentially impact long-term adoption and growth. In the first quarter of 2026, total Dv installation was 11,395 and average system utilization increased by 4% in the US, but OUS volumes in China, Japan, and Europe were impacted by these challenges.
This aggregate rating is based on analysts' research of Intuitive Surgical and is not a guaranteed prediction by Public.com or investment advice.
Intuitive Surgical (ISRG) Analyst Forecast & Price Prediction
Start investing in Intuitive Surgical (ISRG)
Order type
Buy in
Order amount
Est. shares
0 shares